Long-term progression-free survival of apatinib monotherapy for relapsed ovarian cancer: a case report and literature review
Di Zhang,1,2 Jiaqi Huang,1,2 Yulan Sun,2 Qisen Guo11Shandong Cancer Hospital Affiliated to Shandong University, Shandong University, Jinan 250117, People’s Republic of China; 2Shandong Academy of Medical Sciences, Shandong Cancer Hospital and Institute, Shandong Cancer Hospital affiliated...
Main Authors: | Zhang D, Huang J, Sun Y, Guo Q |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-05-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/long-term-progression-free-survival-of-apatinib-monotherapy-for-relaps-peer-reviewed-article-OTT |
Similar Items
-
Apatinib treatment efficiently delays biochemical-only recurrent ovarian cancer progression
by: Zhongyu Wang, et al.
Published: (2021-07-01) -
The Efficacy and Safety of Apatinib in Refractory/Relapse Advanced Pediatric Solid Tumor: A Retrospective Study
by: Sun F, et al.
Published: (2020-07-01) -
A Study Of Efficacy And Safety With Apatinib Or Apatinib Combined With Chemotherapy In Recurrent/advanced Ovarian Cancer Patients
by: Yang M, et al.
Published: (2019-10-01) -
Clinical efficacy and survival analysis of apatinib combined with docetaxel in advanced esophageal cancer
by: Li J, et al.
Published: (2019-04-01) -
Apatinib exhibits anti-leukemia activity in preclinical models of acute lymphoblastic leukemia
by: Manman Deng, et al.
Published: (2018-02-01)